Literature DB >> 25880164

Heterologous surface display on lactic acid bacteria: non-GMO alternative?

Petra Zadravec1, Borut Štrukelj, Aleš Berlec.   

Abstract

Lactic acid bacteria (LAB) are food-grade hosts for surface display with potential applications in food and therapy. Alternative approaches to surface display on LAB would avoid the use of recombinant DNA technology and genetically-modified organism (GMO)-related regulatory requirements. Non-covalent surface display of proteins can be achieved by fusing them to various cell-wall binding domains, of which the Lysine motif domain (LysM) is particularly well studied. Fusion proteins have been isolated from recombinant bacteria or from their growth medium and displayed on unmodified bacteria, enabling heterologous surface display. This was demonstrated on non-viable cells devoid of protein content, termed bacteria-like particles, and on various species of genus Lactobacillus. Of the latter, Lactobacillus salivarius ATCC 11741 was recently shown to be particularly amenable for LysM-mediated display. Possible regulatory implications of heterologous surface display are discussed, particularly those relevant for the European Union.

Entities:  

Keywords:  EFSA; EMA; LysM; bacteria-like particles; cell-wall binding domains; genetically-modified organism; gram-positive enhancer matrix; regulatory agency; surface display

Mesh:

Substances:

Year:  2015        PMID: 25880164      PMCID: PMC4601214          DOI: 10.1080/21655979.2015.1040956

Source DB:  PubMed          Journal:  Bioengineered        ISSN: 2165-5979            Impact factor:   3.269


  20 in total

1.  Novel surface display system for proteins on non-genetically modified gram-positive bacteria.

Authors:  Tjibbe Bosma; Rolf Kanninga; Jolanda Neef; Sandrine A L Audouy; Maarten L van Roosmalen; Anton Steen; Girbe Buist; Jan Kok; Oscar P Kuipers; George Robillard; Kees Leenhouts
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

2.  Environmental risk assessment for medicinal products containing genetically modified organisms.

Authors:  B Anliker; S Longhurst; C J Buchholz
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2010-01       Impact factor: 1.513

3.  LysGH15B, the SH3b domain of staphylococcal phage endolysin LysGH15, retains high affinity to staphylococci.

Authors:  Jingmin Gu; Rong Lu; Xiaohe Liu; Wenyu Han; Liancheng Lei; Yu Gao; Honglei Zhao; Yue Li; Yuwen Diao
Journal:  Curr Microbiol       Date:  2011-09-23       Impact factor: 2.188

4.  Cell wall attachment of a widely distributed peptidoglycan binding domain is hindered by cell wall constituents.

Authors:  Anton Steen; Girbe Buist; Kees J Leenhouts; Mohamed El Khattabi; Froukje Grijpstra; Aldert L Zomer; Gerard Venema; Oscar P Kuipers; Jan Kok
Journal:  J Biol Chem       Date:  2003-04-08       Impact factor: 5.157

5.  Characterization of a novel LysM domain from Lactobacillus fermentum bacteriophage endolysin and its use as an anchor to display heterologous proteins on the surfaces of lactic acid bacteria.

Authors:  Shumin Hu; Jian Kong; Wentao Kong; Tingting Guo; Mingjie Ji
Journal:  Appl Environ Microbiol       Date:  2010-02-19       Impact factor: 4.792

6.  Improvement of LysM-mediated surface display of designed ankyrin repeat proteins (DARPins) in recombinant and nonrecombinant strains of Lactococcus lactis and Lactobacillus Species.

Authors:  Petra Zadravec; Borut Štrukelj; Aleš Berlec
Journal:  Appl Environ Microbiol       Date:  2015-01-09       Impact factor: 4.792

Review 7.  Bacteriophage endolysins as novel antimicrobials.

Authors:  Mathias Schmelcher; David M Donovan; Martin J Loessner
Journal:  Future Microbiol       Date:  2012-10       Impact factor: 3.165

8.  Heterologous protein display on the cell surface of lactic acid bacteria mediated by the s-layer protein.

Authors:  Shumin Hu; Jian Kong; Zhilan Sun; Lanlan Han; Wentao Kong; Pu Yang
Journal:  Microb Cell Fact       Date:  2011-10-28       Impact factor: 5.328

9.  Bacterium-like particles for efficient immune stimulation of existing vaccines and new subunit vaccines in mucosal applications.

Authors:  Natalija Van Braeckel-Budimir; Bert Jan Haijema; Kees Leenhouts
Journal:  Front Immunol       Date:  2013-09-17       Impact factor: 7.561

10.  Molecular basis for bacterial peptidoglycan recognition by LysM domains.

Authors:  Stéphane Mesnage; Mariano Dellarole; Nicola J Baxter; Jean-Baptiste Rouget; Jordan D Dimitrov; Ning Wang; Yukari Fujimoto; Andrea M Hounslow; Sébastien Lacroix-Desmazes; Koichi Fukase; Simon J Foster; Michael P Williamson
Journal:  Nat Commun       Date:  2014-06-30       Impact factor: 14.919

View more
  10 in total

Review 1.  Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications.

Authors:  Josef R Bober; Chase L Beisel; Nikhil U Nair
Journal:  Annu Rev Biomed Eng       Date:  2018-03-12       Impact factor: 9.590

2.  Targeting IL-6 by engineered Lactococcus lactis via surface-displayed affibody.

Authors:  Abida Zahirović; Aleš Berlec
Journal:  Microb Cell Fact       Date:  2022-07-16       Impact factor: 6.352

3.  Is the LysM domain of L. monocytogenes p60 protein suitable for engineering a protein with high peptidoglycan binding affinity?

Authors:  Minfeng Yu; Jing Yang; Minliang Guo
Journal:  Bioengineered       Date:  2016-06-22       Impact factor: 3.269

4.  Evasin-displaying lactic acid bacteria bind different chemokines and neutralize CXCL8 production in Caco-2 cells.

Authors:  Katja Škrlec; Anja Pucer Janež; Boris Rogelj; Borut Štrukelj; Aleš Berlec
Journal:  Microb Biotechnol       Date:  2017-07-24       Impact factor: 5.813

5.  Dual Functionalized Lactococcus lactis Shows Tumor Antigen Targeting and Cytokine Binding in Vitro.

Authors:  Abida Zahirović; Tina Vida Plavec; Aleš Berlec
Journal:  Front Bioeng Biotechnol       Date:  2022-01-26

Review 6.  Functional foods as a formulation ingredients in beverages: technological advancements and constraints.

Authors:  Shagun Sharma; Astha Singh; Swati Sharma; Anil Kant; Surajbhan Sevda; Mohammad J Taherzadeh; Vijay Kumar Garlapati
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

7.  A novel, non-GMO surface display in Limosilactobacillus fermentum mediated by cell surface hydrolase without anchor motif.

Authors:  Robie Vasquez; Bernadette B Bagon; Ji Hoon Song; Nam Soo Han; Dae-Kyung Kang
Journal:  BMC Microbiol       Date:  2022-08-03       Impact factor: 4.465

8.  Development of Recombinant Lactococcus lactis Displaying Albumin-Binding Domain Variants against Shiga Toxin 1 B Subunit.

Authors:  Petra Zadravec; Lucie Marečková; Hana Petroková; Vesna Hodnik; Milica Perišić Nanut; Gregor Anderluh; Borut Štrukelj; Petr Malý; Aleš Berlec
Journal:  PLoS One       Date:  2016-09-08       Impact factor: 3.240

Review 9.  Microbial Delivery Vehicles for Allergens and Allergen-Derived Peptides in Immunotherapy of Allergic Diseases.

Authors:  Abida Zahirović; Mojca Lunder
Journal:  Front Microbiol       Date:  2018-07-02       Impact factor: 5.640

Review 10.  Safety Aspects of Genetically Modified Lactic Acid Bacteria.

Authors:  Tina Vida Plavec; Aleš Berlec
Journal:  Microorganisms       Date:  2020-02-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.